Concepedia

Daniel Wambua

DW

7

Publications

286

Citations

7

H-Index

2011

Active since

Affiliations

Oncor (United States)(Current)

Ragon Institute of MGH, MIT and Harvard

Daniel Wambua is an author at Oncor (United States) specializing in medicine, immunology, and hiv.

Top concepts

Publications per year

2011–2022

7

Publications

7

A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells

Zachary Davis, Andrew C. Cogswell, Hamish W. Scott et al. · PLoS Pathogens · 2016 · 85 citations · Full text

, , +17

ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity

Brian B. Haines, Agnieszka Denslow, Peter Grzesik et al. · Cancer Immunology Research · 2020 · 64 citations · Full text

A Genetic Screen Identifies Interferon-α Effector Genes Required to Suppress Hepatitis C Virus Replication

Dahlene N. Fusco, Cynthia Brisac, Sinu P. John et al. · Gastroenterology · 2013 · 39 citations · Full text

, , +12

Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer

Edward M. Kennedy, Agnieszka Denslow, Jacqueline Hewett et al. · Nature Communications · 2022 · 38 citations · Full text

Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability

Edward M. Kennedy, Terry Farkaly, Peter Grzesik et al. · Molecular Therapy — Oncolytics · 2020 · 24 citations · Full text

Rows per page

1–5 of 7